Schneider Armin, Laage Rico, von Ahsen Oliver, Fischer Achim, Rossner Moritz, Scheek Sigrid, Grünewald Sylvia, Kuner Rohini, Weber Daniela, Krüger Carola, Klaussner Bettina, Götz Bernhard, Hiemisch Holger, Newrzella Dieter, Martin-Villalba Ana, Bach Alfred, Schwaninger Markus
Axaron Bioscience AG, Heidelberg, Germany.
J Neurochem. 2004 Mar;88(5):1114-26. doi: 10.1046/j.1471-4159.2003.02228.x.
Cerebral ischaemia induces transcriptional changes in a number of pathophysiologically important genes. Here we have systematically studied gene expression changes after 90 min and 24 h of permanent focal ischaemia in the mouse by an advanced fragment display technique (restriction-mediated differential display). We identified 56 transcriptionally altered genes, many of which provide novel hints to ischaemic pathophysiology. Particularly interesting were two pro-apoptotic genes (Grim19 and Tdag51), whose role in cerebral ischaemia and neuronal cell death has not been recognized so far. Among the unknown sequences, we identified a gene that was rapidly and transiently up-regulated. The encoded protein displayed high homology to the MARK family of serine-threonine protein kinases and has recently been described as MARKL1/MARK4. Here we demonstrate that this protein is a functional protein kinase with the ability to specifically phosphorylate a cognate peptide substrate for the AMP-kinase family. Upon overexpression in heterologous cells, the functional wild-type protein, but not its kinase-dead mutant, led to decreased cell viability. We conclude that the up-regulation of this kinase during focal ischaemia may represent an interesting new target for pharmacological intervention.
脑缺血会诱导许多在病理生理方面具有重要意义的基因发生转录变化。在此,我们通过一种先进的片段展示技术(限制性介导的差异展示),系统地研究了小鼠永久性局灶性缺血90分钟和24小时后的基因表达变化。我们鉴定出56个转录改变的基因,其中许多为缺血病理生理学提供了新线索。特别有趣的是两个促凋亡基因(Grim19和Tdag51),它们在脑缺血和神经元细胞死亡中的作用迄今尚未被认识到。在未知序列中,我们鉴定出一个迅速且短暂上调的基因。其编码的蛋白质与丝氨酸 - 苏氨酸蛋白激酶的MARK家族具有高度同源性,最近被描述为MARKL1/MARK4。在此我们证明该蛋白质是一种功能性蛋白激酶,能够特异性磷酸化AMP激酶家族的同源肽底物。在异源细胞中过表达时,功能性野生型蛋白而非其激酶失活突变体导致细胞活力下降。我们得出结论,局灶性缺血期间这种激酶的上调可能代表了一个有趣的药物干预新靶点。